Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11040097 Method of conferring a protective immune response to norovirus

Patent 11040097 was granted and assigned to Takeda (company) on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

William Tino0

Charles Richardson0

Thomas R. Foubert0

Thomas S. Vedvick0

Date of Patent

June 22, 2021

Patent Application Number

16870020

Date Filed

May 8, 2020

Patent Citations

US Patent 10010599 Norovirus vaccine formulations

US Patent 10130696 Method of conferring a protective immune response to norovirus

0

US Patent 10167320 Purification of virus like particles

US Patent 10512682 Norovirus vaccine formulations

US Patent 10675341 Parenteral norovirus vaccine formulations

0

US Patent 10688174 Method of conferring a protective immune response to norovirus

0

Patent Citations Received

US Patent 11701420 Parenteral norovirus vaccine formulations

0

Patent Primary Examiner

Barry A Chestnut

Patent abstract

The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11040097 Method of conferring a protective immune response to norovirus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool